VeriMomcetraria islandica thallus/polypodium vulgare rhizome/sphagnum magellanicum extract est-il sûr pendant la grossesse ?
No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR safety assessment for this combined extract name was found in available regulatory sources; no peer‑reviewed evidence of reproductive toxicity, teratogenicity or endocrine disruption associated with Cetraria islandica, Polypodium vulgare or Sphagnum magellanicum extracts. Typical cosmetic use of botanical extracts involves complex, relatively high‑molecular‑weight constituents with low dermal systemic bioavailability, so default exposure rating is low. Sources consulted: ECHA Annex VI (no harmonised H360/H361), CosIng/PubChem listings and lack of CIR/SCCS opinions.
Related ingredients
Frequently asked questions
- cetraria islandica thallus/polypodium vulgare rhizome/sphagnum magellanicum extract est-il sûr pendant la grossesse ?
- No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR safety assessment for this combined extract name was found in available regulatory sources; no peer‑reviewed evidence of reproductive toxicity, teratogenicity or endocrine disruption associated with Cetraria islandica, Polypodium vulgare or Sphagnum magellanicum extracts. Typical cosmetic use of botanical extracts involves complex, relatively high‑molecular‑weight constituents with low dermal systemic bioavailability, so default exposure rating is low. Sources consulted: ECHA Annex VI (no harmonised H360/H361), CosIng/PubChem listings and lack of CIR/SCCS opinions.
- cetraria islandica thallus/polypodium vulgare rhizome/sphagnum magellanicum extract est-il sûr pendant l'allaitement ?
- No evidence located that these extracts cause lactation/transfer concerns or have documented systemic reproductive mechanistic activity. No harmonised classifications or CIR/SCCS assessments flagging breast‑feeding hazards. Expected low systemic absorption from typical topical cosmetic use.
- cetraria islandica thallus/polypodium vulgare rhizome/sphagnum magellanicum extract est-il sûr pour la peau de bébé ?
- No infant‑specific reproductive/dermal toxicity data or harmonised flags found. Because botanical extracts are not absolutely non‑absorbable and infant skin has higher absorption potential, exposure score is increased by +1 for 0–3 year skin (from adult 0 to 1) per the scoring rules; hazard/mechanism remain 0 in absence of evidence of reproductive hazard or mechanistic activity.
- Comment VeriMom évalue-t-il cetraria islandica thallus/polypodium vulgare rhizome/sphagnum magellanicum extract ?
- VeriMom évalue cetraria islandica thallus/polypodium vulgare rhizome/sphagnum magellanicum extract à 100/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à cetraria islandica thallus/polypodium vulgare rhizome/sphagnum magellanicum extract pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à cetraria islandica thallus/polypodium vulgare rhizome/sphagnum magellanicum extract basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.